Trial Profile
An Exploratory, Double-Blind, Randomized, Placebo and Active-Controlled Study to Assess the Safety and Efficacy of RGH-478 for the Treatment of Moderate to Severe Pain in Osteoarthritis of the Knee
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 30 Nov 2012
Price :
$35
*
At a glance
- Drugs RGH 478 (Primary) ; Celecoxib
- Indications Musculoskeletal pain; Osteoarthritis
- Focus Therapeutic Use
- 08 Aug 2012 Status changed from recruiting to completed as reported by European Clinical Trials Database.
- 10 Oct 2011 New trial record